Joshua Z Goldenberg
Overview
Explore the profile of Joshua Z Goldenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
1019
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hawrelak J, Wohlmuth H, Pattinson M, Myers S, Goldenberg J, Harnett J, et al.
Complement Ther Med
. 2020 Jan;
48:102233.
PMID: 31987249
Objective: To evaluate the efficacy of Western herbal medicines in the treatment of irritable bowel syndrome (IBS). Design: A computer-based search of MEDLINE, EMBASE, CINAHL, AMED, GreenFILE, Health Source: Nursing/Academic...
12.
Goldenberg J, Brignall M, Hamilton M, Beardsley J, Batson R, Hawrelak J, et al.
Cochrane Database Syst Rev
. 2019 Nov;
2019(11).
PMID: 31713856
Background: Irritable bowel syndrome (IBS) is a prevalent condition that currently lacks highly effective therapies for its management. Biofeedback has been proposed as a therapy that may help individuals learn...
13.
Carter T, Goldenberg J, Steel A
Integr Med Res
. 2019 Aug;
8(3):209-215.
PMID: 31467841
Background: Functional gastrointestinal disorders (FGID) affect more than one-third of the general population and contribute a considerable burden on the health and wellbeing of the community and the economy. This...
14.
Guo Q, Goldenberg J, Humphrey C, El Dib R, Johnston B
Cochrane Database Syst Rev
. 2019 May;
4:CD004827.
PMID: 31039287
Background: Antibiotics alter the microbial balance commonly resulting in antibiotic-associated diarrhea (AAD). Probiotics may prevent AAD via providing gut barrier, restoration of the gut microflora, and other potential mechanisms of...
15.
Goldenberg J, Steel A, Day A, Yap C, Bradley R, Cooley K
Integr Med Res
. 2018 Oct;
7(3):279-286.
PMID: 30271717
Background: Irritable bowel syndrome (IBS) is a common functional bowel disorder with a worldwide prevalence estimated between 10% and 20%. It has a significant impact on quality of life and...
16.
Logan A, Goldenberg J, Guiltinan J, Seely D, Katz D
Explore (NY)
. 2018 Sep;
14(5):367-372.
PMID: 30217641
The World Health Organization strategy for global health includes a culturally-sensitive blending of western biomedicine with traditional forms of healing; in practical terms this approach is often referred to as...
17.
Goldenberg J, Ward L, Day A, Cooley K
J Altern Complement Med
. 2018 Sep;
25(2):227-233.
PMID: 30207740
Introduction: Irritable bowel syndrome (IBS) affects 11% of the population, and up to 50% of patients report using complementary and alternative medicines (CAM) for it. To date, there is no...
18.
Goldenberg J, Mertz D, Johnston B
JAMA
. 2018 Jul;
320(5):499-500.
PMID: 30027207
Clinical Question: In adults and children prescribed antibiotics, is co-administration of a probiotic associated with a lower risk of symptomatic Clostridium difficile infection without an increase in adverse events? Bottom...
19.
Johnston B, Lytvyn L, Lo C, Allen S, Wang D, Szajewska H, et al.
Infect Control Hosp Epidemiol
. 2018 Apr;
39(7):771-781.
PMID: 29695312
OBJECTIVETo determine whether probiotic prophylaxes reduce the odds of Clostridium difficile infection (CDI) in adults and children.DESIGNIndividual participant data (IPD) meta-analysis of randomized controlled trials (RCTs), adjusting for risk factors.METHODSWe...
20.
Goldenberg J, Yap C, Lytvyn L, Lo C, Beardsley J, Mertz D, et al.
Cochrane Database Syst Rev
. 2017 Dec;
12:CD006095.
PMID: 29257353
Background: Antibiotics can disturb gastrointestinal microbiota which may lead to reduced resistance to pathogens such as Clostridium difficile (C. difficile). Probiotics are live microbial preparations that, when administered in adequate...